GlycoVaxyn

Vaxdyn

Vaxdyn develops multivalent vaccines to prevent antibiotic-resistant bacterial infections for high-risk populations, including hospital patients and those with chronic diseases.

MinervaX

This biotechnology company develops a protein-based vaccine against Group B Streptococcus for pregnant women, newborns, and older adults.

GIVAX

This biotechnology company develops oral mucosal vaccines to protect children and adults against gastrointestinal diseases like rotavirus and norovirus.

Cytos Biotechnology AG

This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.

Affinivax

This biopharmaceutical company develops vaccines against infectious diseases and hospital-associated infections for healthcare providers and public health organisations worldwide.

ArkVax

ArkVax develops low-cost recombinant glycoconjugate vaccines for the livestock industry to protect animals from bacterial diseases and combat antimicrobial resistance.

CHAIN Biotech

This biotechnology company develops oral vaccines and microbiome therapeutics using engineered bacteria to treat solid tumour cancers and chronic diseases for pharmaceutical partners.

Baseimmune

The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.